Callan Family Office’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$220K Sell
1,268
-1,745
-58% -$358K 0.01% 1038
2025
Q4
$772K Buy
3,013
+1,809
+150% +$474K 0.02% 620
2025
Q3
$313K Sell
1,204
-16
-1% -$4.21K 0.01% 695
2025
Q2
$298K Buy
+1,220
New +$304K 0.01% 775
2025
Q1
Sell
-842
Closed -$214K 594
2024
Q4
$214K Buy
+842
New +$226K 0.01% 586

Other funds holding HUM

Callan Family Office's HUM Position: Q1 2026 in Review

Callan Family Office reduced its Humana (HUM) stake by 58% in Q1 2026, selling an estimated $358K and leaving 1,268 shares worth $220K. The position accounts for 0.01% of the portfolio, ranked #1038.

Callan Family Office first reported a position in HUM in Q4 2024 and has held it in 5 quarters since. The position peaked at $772K in Q4 2025. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • Callan Family Office held 1,268 shares of Humana worth $220K as of Q1 2026.
  • Callan Family Office sold 1,745 Humana shares in Q1 2026, an estimated $358K.
  • Humana made up 0.01% of Callan Family Office's portfolio in Q1 2026, its #1038 holding.
  • Callan Family Office first reported a position in Humana in Q4 2024 and has held it in 5 quarters since.
  • Callan Family Office's Humana position peaked at $772K in Q4 2025.
  • 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.